Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: A phase III, randomized, open-label trial

Nicholas J. Robert, Mansoor N. Saleh, Devchand Paul, Daniele Generali, Laurent Gressot, Mehmet S. Copur, Adam M. Brufsky, Susan E. Minton, Jeffrey K. Giguere, John W. Smith, Paul D. Richards, Diana Gernhardt, Xin Huang, Katherine F. Liau, Kenneth A. Kern, John Davis

Research output: Contribution to journalArticlepeer-review

111 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: A phase III, randomized, open-label trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science